ReviewLancet (London, England)2020
Active case finding with case management: the key to tackling the COVID-19 pandemic.
Review in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
192 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Implementing Public Health Strategies-The Need for Educational Initiatives: A Systematic Review.International journal of environmental research and public health · 2021Pooled it
- Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review.International journal of environmental research and public health · 2021Pooled it
- Evaluating patient satisfaction and perceived accuracy in questionnaires completed before vs. during a pain clinic visit.Pain management · 2025Trial
- Improving the efficiency of identifying malignant pulmonary nodules before surgery via a combination of artificial intelligence CT image recognition and serum autoantibodies.European radiology · 2023Trial
- Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021Trial
- The impact of public health and social measures on social contact patterns and transmission of COVID-19 in Hong Kong.BMC medicine · 2026Article
- Omissions in nurses' infection prevention and control practices and their contributing factors: a CFIR-based sequential explanatory mixed-methods study.BMC nursing · 2026Article
- Epidemiological Trends of COVID-19 Infection and Symptom Incidence in China Following the Adjustment of Zero-COVID Policy: A Prospective, Community-Based Cohort Study.Transboundary and emerging diseases · 2026Article
- Genomic characterization and evolutionary dynamics of human adenovirus C (HAdV-C) in Beijing (2023-2024): insights into multiple recombination and adaptive evolution.Virus evolution · 2026Article
- Impact of COVID-19 Control Measures on Birth Outcomes in Ho Chi Minh City, Vietnam.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2025Article
- Trends in Avoidable Hospitalizations Before and During the COVID-19 Pandemic: Multiple Cross-Sectional Study Using Administrative Data From Beijing, China.JMIR public health and surveillance · 2025Article
- Distance Learning During the COVID-19 Lockdown and Self-Assessed Competency Development Among Radiology Residents in China: Cross-Sectional Survey.JMIR medical education · 2025Article
- Information-guided adaptive learning approach for active surveillance of infectious diseases.Infectious Disease Modelling · 2025Article
- Comparative analysis between genotypes of adenovirus isolates from hospitalized children with acute respiratory tract infections and clinical manifestations in Wuhan, China, from June 2022 to September 2023.Virologica Sinica · 2025Article
- The strategy to control the outbreak of an emerging respiratory infectious disease in a simulated Chinese megacity.Heliyon · 2025Article
- Reagent efficiency and analytical sensitivity optimization for a reliable SARS-CoV-2 pool-based testing strategy.Heliyon · 2025Article
- Article
- Multiplex droplet digital PCR for the detection and quantitation ofFrontiers in cellular and infection microbiology · 2025Article
- Efficiency evaluation on case finding strategy for COVID-19 outbreak control under China's "dynamic zero-case policy": a retrospective field epidemiology study.Frontiers in public health · 2025Observational
- Lower respiratory tract co-infection ofFrontiers in cellular and infection microbiology · 2025Article
132 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 was declared a pandemic by WHO on March 11, 2020, the first non-influenza pandemic, affecting more than 200 countries and areas, with more than 5·9 million cases by May 31, 2020. Countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. We describe China's strategies for prevention and control of COVID-19 (containment and suppression) and their application, from the perspective of the COVID-19 experience to date in China. Although China has contained severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and nearly stopped indigenous transmission, a strong suppression effort must continue to prevent re-establishment of community transmission from importation-related cases. We believe that case finding and management, with identification and quarantine of close contacts, are vitally important containment measures and are essential in China's pathway forward. We describe the next steps planned in China that follow the containment effort. We believe that sharing countries' experiences will help the global community manage the COVID-19 pandemic by identifying what works in the struggle against SARS-CoV-2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.